Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Enliven Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- +4 vs. Q1 2025
- Shares held
- 59.4M
- +9.55M (+19.1%) vs. Q1 2025
- Total value
- $1.19B
- +$208.3M (+21.2%) vs. Q1 2025
- New holders
- 24
- 57 more added
- Sold out
- 20
- 23 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 (DIFC) Ltd | 1,536 | $30.8K | 0.00% | +1,536 | New |
| GF Fund Management Co. Ltd. | 1,251 | $25.1K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,218 | $24.0K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 705 | $14.1K | 0.00% | +23+3.4% | Added |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 383 | $8.00K | 0.00% | +383 | New |
| Versant Capital Management, Inc | 279 | $5.60K | 0.00% | +212+316.4% | Added |
| GAMMA Investing LLC | 201 | $4.03K | 0.00% | +63+45.7% | Added |
| Daiwa Securities Group Inc. | 152 | $3.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 183 | $3.00K | 0.00% | +133+266.0% | Added |
| Advisor Group Holdings, Inc. | 149 | $2.99K | 0.00% | +149 | New |
| Larson Financial Group LLC | 119 | $2.39K | 0.00% | +119 | New |
| US Bancorp | 111 | $2.23K | 0.00% | +111 | New |
| CWM, LLC | 91 | $2.00K | 0.00% | +61+203.3% | Added |
| Massmutual Trust Co FSB | 84 | $1.69K | 0.00% | 00.0% | Unchanged |
| Sterling Capital Management LLC | 81 | $1.63K | 0.00% | +14+20.9% | Added |
| IFP Advisors, Inc | 0 | $1.34K | 0.00% | 0 | Unchanged |
| EverSource Wealth Advisors, LLC | 63 | $1.26K | 0.00% | +50+384.6% | Added |
| Rothschild Investment LLC | 45 | $903 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 38 | $763 | 0.00% | +38 | New |
| SBI Securities Co., Ltd. | 37 | $742 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 28 | $562 | 0.00% | +18+180.0% | Added |
| Signaturefd, LLC | 26 | $522 | 0.00% | +26 | New |
| Parkside Financial Bank & Trust | 25 | $502 | 0.00% | +25 | New |
| Farther Finance Advisors, LLC | 6 | $120 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 6 | $0 | 0.00% | 00.0% | Unchanged |
| Boxer Capital Management, LLC | 0 | $0 | 0.00% | −671,358−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −289,538−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −265,269−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −197,279−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −120,430−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −76,975−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −33,984−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −33,547−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −32,573−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −19,997−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −17,925−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −13,363−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,125−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −6,055−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −776−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −215−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| TD Capital Management LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |